Edward C. Saltzman - 12 Sep 2022 Form 3 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role
Director
Signature
/s/ Christine Ring, as Attorney-in-Fact for Edward C. Saltzman
Issuer symbol
NRIX
Transactions as of
12 Sep 2022
Net transactions value
$0
Form type
3
Filing time
14 Sep 2022, 16:24:24 UTC
Next filing
04 May 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney No securities are beneficially owned.